BLCO Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 Mai 2024 @ 22:00):

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical...

Stats
Tagesvolumen	1.10M
Durchschnittsvolumen	484 852
Marktkapitalisierung	4.86B
EPS	$0.240 ( 2024-05-01 )
Nächstes Ertragsdatum	( $0 ) 2024-07-31
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-14.44
ATR14	$0.0220 (0.16%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-24	Stewart Andrew J.	Sell	3 943	Common Shares, No Par Value
2024-04-24	Bailey A Robert D	Sell	9 838	Common Shares, No Par Value
2024-03-29	Robertson Russel C	Buy	1 481	Common Shares, No Par Value
2024-03-29	Paulson John	Buy	1 264	Common Shares, No Par Value
2024-03-29	De Schutter Richard U	Buy	1 553	Common Shares, No Par Value

INSIDER POWER
-8.64
Last 94 transactions
Buy: 2 803 512 \| Sell: 8 839 600

Volumen Korrelation

Lang: 0.11 (neutral)

Kurz: 0.92 (very strong)

Signal:(58.79) Expect same movement, but be aware

Bausch + Lomb Corporation Korrelation

10 Am meisten positiv korreliert
BPMP	0.903
ARC	0.848
BMA	0.847
TPR	0.84
HSBC	0.834
BIP-PA	0.83
CMCM	0.829
BFS-PD	0.826
SUPV	0.818
ANF	0.818

10 Am meisten negativ korreliert
EPV	-0.803

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Bausch + Lomb Corporation Korrelation - Währung/Rohstoff

0.02
( neutral )

-0.23
( neutral )

0.00
( neutral )

-0.47
( neutral )

-0.59
( weak negative )

0.57
( weak )

Bausch + Lomb Corporation Finanzdaten

Annual	2023
Umsatz:	$4.15B
Bruttogewinn:	$2.50B (60.40 %)
EPS:	$-0.740

FY	2023
Umsatz:	$4.15B
Bruttogewinn:	$2.50B (60.40 %)
EPS:	$-0.740

FY	2022
Umsatz:	$3.77B
Bruttogewinn:	$2.25B (59.69 %)
EPS:	$0.0429

FY	2021
Umsatz:	$3.77B
Bruttogewinn:	$2.30B (61.04 %)
EPS:	$0.520

Financial Reports:

No articles found.

Bausch + Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.